Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD).
about
Physical function and quality of life in patients with chronic GvHD: a summary of preclinical and clinical studies and a call for exercise intervention trials in patientsLow incidence of severe cGvHD and late NRM in a phase II trial of thymoglobulin, tacrolimus and sirolimus for GvHD prevention.Vaccination against pandemic H1N1 (2009) in patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis.Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease.Attenuation of cGVHD by C5a/C5aR blockade is associated with increased frequency of TregPatient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD ConsortiumFavorable outcomes in patients surviving 5 or more years after allogeneic hematopoietic stem cell transplantation for hematologic malignanciesFunction, adjustment, quality of life and symptoms (FAQS) in allogeneic hematopoietic stem cell transplantation (HSCT) survivors: a study protocol.Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of diseaseClinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity.Physical Exercise Training versus Relaxation in Allogeneic stem cell transplantation (PETRA Study) - Rationale and design of a randomized trial to evaluate a yearlong exercise intervention on overall survival and side-effects after allogeneic stem cHealth-related quality of life following allogeneic hematopoietic stem cell transplantation.Functional evaluation indicates physical losses after hematopoietic stem cell transplantationSpiritual Well-Being in Hispanic and Non-Hispanic Survivors of Allogeneic Hematopoietic Stem Cell Transplantation.Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group reporWhich questionnaires should we use to evaluate quality of life in patients with chronic graft-vs-host disease?Predictive models for ocular chronic graft-versus-host disease diagnosis and disease activity in transplant clinical practice.National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis.High frequency of cutaneous manifestations including vitiligo and alopecia areata in a prospective cohort of patients with chronic graft-vs-host disease.Glycoprotein YKL-40: a novel biomarker of chronic graft-vs-host disease activity and severity?Vitamin D levels and their associations with survival and major disease outcomes in a large cohort of patients with chronic graft-vs-host disease.Joint and fascial chronic graft-vs-host disease: correlations with clinical and laboratory parameters.Quantitative salivary proteomic differences in oral chronic graft-versus-host disease.Child and parent perspectives of the chronic graft-versus-host disease (cGVHD) symptom experience: a concept elicitation study.Comorbidity burden in patients with chronic GVHDSymptom distress predicts long-term health and well-being in allogeneic stem cell transplantation survivors.Personality influences quality-of-life assessments in adult patients after allogeneic hematopoietic SCT: results from a joint evaluation of the prospective German Multicenter Validation Trial and the Fred Hutchinson Cancer Research Center.Regulatory element-based prediction identifies new susceptibility regulatory variants for osteoporosis.NIH response criteria measures are associated with important parameters of disease severity in patients with chronic GVHD.Characterization and Risk Factor Analysis of Osteoporosis in a Large Cohort of Patients with Chronic Graft-versus-Host Disease.Prevalence and determinants of fatigue in patients with moderate to severe chronic GvHD.Malnutrition in patients with chronic GVHDTranslation, Cross-Cultural Adaptation, and Validation of the Lee Chronic Graft-versus-Host Disease Symptom Scale in a Brazilian Population.Importance of functional evaluation after hematopoietic cell transplantation.Improvement of quality of life in patients with steroid-refractory chronic graft-versus-host disease treated with the mTOR inhibitor everolimus.Differences in health behaviour between recipients of allogeneic haematopoietic SCT and the general population: a matched control study.Cardiopulmonary fitness in patients undergoing hematopoietic SCT: a pilot study.Effects of exercise interventions in graft-versus-host disease models.The lack of memory B cells including T cell independent IgM+ IgD+ memory B cells in chronic graft-versus host disease is associated with susceptibility to infection.Efficacy of exercise training in SCT patients--who benefits most?
P2860
Q26787230-8E957A00-D0FF-45F4-AC1E-0F0AF56A3B19Q30252205-4CE7045E-6538-4019-8970-6DAEB4FC1DF2Q30408740-2C404A95-5A80-4DAB-8AF5-119680D67499Q33725411-1107BE44-6448-4E9A-A8EF-275D460FA125Q33804224-EF0857FA-42D4-48E5-85FE-BE2FCC7A9B29Q33830644-B3A9B4C5-7408-4007-8608-B16AD4794EC6Q33965200-3C0105EF-0831-46CD-A8FD-8EE1AAC3EF85Q35003711-302CE0FB-F8D9-485B-8721-609FF1CE32E8Q35483838-D6F005FC-3868-48B2-8EA1-22A7BD45E2A6Q35685660-BC645D18-F818-4DBF-B154-1BDE8D1F7679Q35765750-250BFB2C-F500-47A6-B77A-A9DDA8E98B7AQ36286379-F7028971-B448-4E1F-AD31-D0EF258EA7CBQ36364830-CA6AC3DE-1D3B-465C-9E6A-851B0F55DC85Q36549460-D0A61588-7368-4EDE-81F6-94952C02E2D3Q36554724-42F89000-8E2E-4513-939E-3B39E7239514Q36707816-F2BAD8A5-0F97-4E3B-9EB7-750AE0DFB12FQ36708947-F9B217EB-DB1E-4D1F-B424-275723F049E1Q36747224-4C89491D-363C-4492-BF77-284B8BCF0EBDQ37075979-6B09354C-3D06-4459-BBFB-073EC929DD76Q37075990-75CBD29D-5A6A-4C11-A329-0C7EC9B4A105Q37075994-5FBF2C95-4BC3-4DA9-94BF-A992EC4679C5Q37076010-988970D4-5ECC-4292-8057-190A49BC1428Q37247158-90764D0D-015B-4989-8E18-21CD5A6D2ADDQ37524846-7CFFEB2D-E7F1-4089-BBD2-B517AF432C3DQ37609043-E188DDCF-7597-499F-9DDC-2AEEF97D9BA6Q37656904-48131438-4BC8-4F77-8194-0C2830D9157CQ37724580-A46E45C6-0BD1-4D74-B5BA-CEB6194A928EQ38699581-F06FE0D8-092E-4CDB-AD48-9F67A0643B0AQ39140290-B9DCC9E2-AFC7-4EB9-94B7-E224C4A0F2FEQ39818593-A9D223E4-A209-435E-A815-6F0890AAA8CDQ40038510-3D2714F1-4961-481F-B6EE-6B2CA6A9C3E0Q41180848-BC41E899-BA48-4AF7-B2E5-954D7E52411EQ41529149-F6CF3000-91D0-483F-98C3-6E979207E635Q41561708-4BBA740C-4D48-4191-87D5-71996CA5843BQ43413019-1A967FF9-B428-4A5D-8CEA-D0CBAD324CF4Q44209882-6C5CF011-2C7B-4923-82B5-D5671CF457AAQ45143552-514EBE57-C047-4152-A7EB-6BA3ADEF346CQ45324881-B2131594-9B11-405F-98C6-6C86D127C2B8Q45771083-57FB1F3F-B5F9-402E-99C1-00C211864643Q45915123-0CCFC38B-DBC8-4AA2-BF05-A94FB7069AE9
P2860
Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD).
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Determinants of functional per ...... t-versus-host disease (cGVHD).
@ast
Determinants of functional per ...... t-versus-host disease (cGVHD).
@en
type
label
Determinants of functional per ...... t-versus-host disease (cGVHD).
@ast
Determinants of functional per ...... t-versus-host disease (cGVHD).
@en
prefLabel
Determinants of functional per ...... t-versus-host disease (cGVHD).
@ast
Determinants of functional per ...... t-versus-host disease (cGVHD).
@en
P2093
P2860
P356
P1476
Determinants of functional per ...... ft-versus-host disease (cGVHD)
@en
P2093
D H Fowler
K H Mooney
N Kline Leidy
P C LaStayo
S A Mitchell
P2860
P2888
P304
P356
10.1038/BMT.2009.238
P407
P577
2009-09-28T00:00:00Z
P5875
P6179
1029769248